---
permalink: /experiences/
title: "Experiences"
excerpt: "Experiences"
author_profile: true
redirect_from: 
  - /experiences.html
  - /
---

*(Last Updated: July 2022)*

## Research Experience

**Aug., 2018 - June, 2020**  
M.Sc. in Medicinal Chemistry  
Advisor: Liangren Zhang  
*@ Drug Design Center (DDC), State Key Laboratory of Natural and Biomimetic Drugs (SKLNBD), SPS, PKU*  
Graduate courses: Advanced Medicinal Chemistry, Advanced Organic Chemistry.  
Focus on incorporating machine learning method into computational models to speed up the early stage of drug discovery.  

**Aug., 2014 - June, 2018**  
B.Sc. in Pharmaceutical Sciences  
Advisor: Liangren Zhang  
*@ SPS, PKU*  
Selected courses: Computer Aided Drug Design, Medicinal Chemistry, Structural Chemistry, Organic Chemistry.

*External Links:*  
[*Drug Design Center*](http://www.pkuddc.com/index.jsp)  
[*State Key Laboratory of Natural and Biomimetic Drugs*](http://sklnbd.bjmu.edu.cn/)  
[*Peking University*](https://pku.edu.cn/index.htm)


## Research Experience


**TF3P: Three-dimensional Force Fields Fingerprint Learned by Deep Capsular Network.**  
Nov. 2018 - May 2020 *@ DDC, SKLNBD, PKU*

- Developed a new 3D fingerprint, TF3P, using the deep capsular network;
- TF3P outperforms other fingerprints on retrieving similar targets by similar ligands.

**DeepScaffold: A Comprehensive Tool for Scaffold-Directed Drug Discovery Using Deep Learning**  
Aug. 2018 - June. 2019 *@ DDC, SKLNBD, PKU*

- Developed graph-based deep generative models for scaffold-based molecular derivatization;
- Demonstrated the excellent performance of the model using molecular docking.

**Discovery of Novel Inhibitors of Glycogen Synthase Kinase-3$\alpha$ for Treatment of Acute Myeloid Leukemia**  
Aug. 2017 - Dec. 2018 *@ DDC, SKLNBD, PKU*

- Identified a novel chemical series of GSK-3$\alpha$ inhibitors by structure-based virtual screening;
- Summarized the structure-activity relationship (SAR) by similarity search;
- Demonstrate their excellent anti-leukemia effects *in vitro*;
- Elucidated the SAR by molecular docking and dynamics simulations.

**QSAR of Acylphloroglucinol-Based Meroterpenoid Inhibitors of KSHV From *Hypericum Japonicum***  
Jan. 2018 - Mar. 2018 *@ DDC, SKLNBD, PKU*

- Field-based 3D QSAR of KSHV inhibitors extracted from *Hypericum japonicum*.

**Discovery of New GSK-3$\beta$ Inhibitors Through Structure-Based Virtual Screening**  
Apr. 2017 - Aug. 2017 *@ DDC, SKLNBD, PKU*

- Binding modes prediction by molecular docking and dynamics simulations.

**Activating Thioesterification in Synthesis of Peptidyl Thioesters by Peroglutamyl Imide**  
Feb. 2017 - Mar. 2017 *@ Dong Group, SKLNBD, PKU*

- Synthesis of peptide-glutamylhydrazine-resin complex.

**Internal Activation of Peptidyl Selenoprolyl Thioester in Peptide Ligation in Pro-Cys Site**  
July 2016 - Jan. 2017 *@ Dong Group, SKLNBD, PKU*

- Synthesis of $\gamma$-selenoproline;
- Synthesis of selenocystine;
- Synthesis of west-side peptidyl thioesters.

**Synthesis of Proline Derivatives**  
July 2015 - Aug. 2016 *@ Dong Group, SKLNBD, PKU*

- Lab skills training on organic synthesis.

*External Links:*  
[*Drug Design Center*](http://www.pkuddc.com/index.jsp)  
[*Dong Group*](http://sklnbd.bjmu.edu.cn/k/e/action/ListInfo/?classid=238)

## Teaching Experience

**Computer Aided Drug Design Lab (Fall 2018 & Spring 2018)**  
Teaching Assistant, Instructor: Prof. Yan Niu  
*@ SPS, PKU*

- Teached students how to use scientific software related to drug design, including Sybyl, Discovery Studio, and Gaussian;
- Supervised students to do projects, including QSAR, binding mode prediction, and molecular geometry optimization.

## Conference

**Nov. 2019, The 15th National Conference on Computer Chemistry of China**  
Attendee & Poster Presenter *@ Shanghai, China*

**Aug. 2019, Chinese Medicinal Chemistry Symposium (CMCS) & CPA-EFMC International Symposium on Medicinal Chemistry (CPA-EFMC ISMC)**  
Attendee & Poster Presenter *@ Chengdu, China*

**Oct. 2017, The 1st International Symposium on Frontiers of Natural and Biomimetic Drugs-Innovations on Drugs Driven by the Integration of Chemical Biology**  
Attendee *@ Beijing, China*

**Aug. 2017, Chinese Medicinal Chemistry Symposium (CMCS) & CPA-EFMC International Symposium on Medicinal Chemistry (CPA-EFMC ISMC)**  
Attendee *@ Beijing, China*

## Internship

**[StoneWise Technology Co., Ltd.](http://www.stonewise.cn/home)**  
Oct. 2018 - Jan. 2019 *@ Beijing, China*  
Intern in algorithm group  
Involved in scaffold-based molecular generation

**[XtalPi Inc.](http://www.xtalpi.com/)**  
Oct. 2017 - Feb. 2018 *@ Beijing, China*  
Intern in algorithm group  
Involved in binding affinity prediction and discovery of IDO inhibitor
